Acknowledgement
Supported by : Korea Research Foundation, KOSEF
References
- Baek, S. H. (2006) A novel link between SUMO modification and cancer metastasis. Cell Cycle 5, 1492−1495 https://doi.org/10.4161/cc.5.14.3008
- Baek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., et al. (2002) Exchange of N-CoR corepressor and Tip60 coactivaotr complexes links gene expression by NF-kB and beta-amyloid precursor protein. Cell 110, 55−67 https://doi.org/10.1016/S0092-8674(02)00809-7
- Binda, O., Roy, J. S., and Branton, P. E. (2006) RBP1 family proteins exhibit SUMOylation-dependent transcriptional repression and induce cell growth inhibition reminiscent of senescence. Mol. Cell Biol. 26, 1917−1931
- Bode, A. M. and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793−805 https://doi.org/10.1038/nrc1455
- Bossis, G., Malnou, C. E., Farras, R., Andermarcher, E., Hipskind, R., et al. (2005) Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell Biol. 25, 6964−6979 https://doi.org/10.1128/MCB.25.16.6964-6979.2005
- Brooks, C. L. and Gu, W. (2006) p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21, 307−315 https://doi.org/10.1016/j.molcel.2006.01.020
- Callewaert, L., Verrijdt, G., Haelens, A., and Claessens, F. (2004) Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol. Endocrinol. 18, 1438−1449 https://doi.org/10.1210/me.2003-0313
- Chen, L. and Chen, J. (2003) MDM2-ARF complex regulates p53 sumoylation. Oncogene 22, 5348−5357 https://doi.org/10.1038/sj.onc.1206851
- Cheng, J., Wang, D., Wang, Z., and Yeh, E. T. (2004) SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol. Cell Biol. 24, 6021−6028 https://doi.org/10.1128/MCB.24.13.6021-6028.2004
- Cheng, J., Bawa, T., Lee, P., Gong, L., and Yeh, E. T. (2006) Role of desumoylation in the development of prostate cancer. Neoplasia. 8, 667−676 https://doi.org/10.1593/neo.06445
- Choi, S. J., Chung, S. S., Rho, E. J., Lee, H. W., Lee, M. H., et al. (2006) Negative modulation of RXRalpha transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO-specific protease SUSP1. J. Biol. Chem. 281, 30669−30677 https://doi.org/10.1074/jbc.M604033200
- Dai, M. S., Jin, Y., Gallegos, J. R., and Lu, H. (2006). Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia 8, 630−644 https://doi.org/10.1593/neo.06334
- Desterro, J. M., Thomson, J., and Hay, R. T. (1997) Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417, 297−300
- Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2, 233−239 https://doi.org/10.1016/S1097-2765(00)80133-1
- Desterro, J. M., Rodriguez, M. S., Kemp, G. D., and Hay, R. T. (1999) Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10618−10624 https://doi.org/10.1074/jbc.274.15.10618
- Devoy, A., Soane, T., Welchman, R., and Mayer, R. J. (2005) The ubiquitin-proteasome system and cancer. Essays Biochem. 41, 187−203 https://doi.org/10.1042/EB0410187
- Doniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A., and You, M. (2002) Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin. Cancer Res. 8, 1127−1138
- Feigelson, H. S. and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279−2284
- Gao, M. and Karin, M. (2005). Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol. Cell 19, 581−593 https://doi.org/10.1016/j.molcel.2005.08.017
- Gong, L., Li, B., Millas, S., and Yeh, E. T. (1999) Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett. 448, 185−189 https://doi.org/10.1016/S0014-5793(99)00367-1
- Gong, L., Millas, S., Maul, G. G., and Yeh, E. T. (2000) Differential regulation of sentrinized proteins by a novel sentrinspecific protease. J. Biol. Chem. 275, 3355−3359
- Gong, Z., Brackertz, M., and Renkawitz, R. (2006) SUMO modification enhances p66-mediated transcriptional repression of the Mi-2/NuRD complex. Mol. Cell Biol. 26, 4519−4528 https://doi.org/10.1128/MCB.00409-06
- Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., et al. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462−6471 https://doi.org/10.1093/emboj/18.22.6462
- Harvey, M., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., Bradley, A., et al. (1993) Spontaneous and carcinogeninduced tumorigenesis in p53-deficient mice. Nat. Genet. 5, 225−229 https://doi.org/10.1038/ng1193-225
- Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell 18, 1−12 https://doi.org/10.1016/j.molcel.2005.03.012
- Hochstrasser, M. (2001) SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107, 5−8 https://doi.org/10.1016/S0092-8674(01)00519-0
- Hochstrasser, M. (2006) Lingering mysteries of ubiquitin-chain assembly. Cell 124, 27−34 https://doi.org/10.1016/j.cell.2005.12.025
- Honda, R., Tanaka, H., and Yasuda, H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25−27
- Hsu, Y. H., Sarker, K. P., Pot, I., Chan, A., Netherton, S. J., et al. (2006) Sumoylated SnoN represses transcription in a promoter- specific manner. J. Biol. Chem. 281, 33008−33018 https://doi.org/10.1074/jbc.M604380200
- Huang, T. T., Wuerzberger-Davis, S. M., Wu, Z. H., and Miyamoto, S. (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115, 565−576 https://doi.org/10.1016/S0092-8674(03)00895-X
- Huang, D. T., Walden, H., Duda, D., and Schulman, B. A. (2004) Ubiquitin-like protein activation. Oncogene 23, 1958−1971 https://doi.org/10.1038/sj.onc.1207393
- Jacques, C., Baris, O., Prunier-Mirebeau, D., Savagner, F., Rodien, P., et al. (2005) Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J. Clin. Endocrinol. Metab. 90, 2314−2320 https://doi.org/10.1210/jc.2004-1337
- Johnson, E. S. (2004) Protein modification by SUMO. Annu. Rev. Biochem. 73, 355−382 https://doi.org/10.1146/annurev.biochem.73.011303.074118
- Johnson, E. S. and Blobel, G. (1997) Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799−26802 https://doi.org/10.1074/jbc.272.43.26799
- Johnson, E. S., Schwienhorst, I., Dohmen, R. J., and Blobel, G. (1997) The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16, 5509−5519 https://doi.org/10.1093/emboj/16.18.5509
- Kagey, M. H., Melhuish, T. A., and Wotton, D. (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113, 127−137 https://doi.org/10.1016/S0092-8674(03)00159-4
- Karin, M. (2006) NF-kappaB and cancer: mechanisms and targets. Mol. Carcinog. 45, 355−361 https://doi.org/10.1002/mc.20217
- Karin, M. and Greten, F. R. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749−759 https://doi.org/10.1038/nri1703
- Kim, K. I., Baek, S. H., Jeon, Y. J., Nishimori, S., Suzuki, T., et al. (2000) A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J. Biol. Chem. 275, 14102−14106 https://doi.org/10.1074/jbc.275.19.14102
- Kim, K. I., Baek, S. H., and Chung, C. H. (2002) Versatile protein tag, SUMO: its enzymology and biological function. J. Cell Physiol. 191, 257−268
- Kim, J. H., Kim, B., Cai, L., Choi, H. J., Ohgi, K. A., et al. (2005) Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 434, 921− 926 https://doi.org/10.1038/nature03452
- Kim, J. H., Choi, H. J., Kim, B., Kim, M. H., Lee, J. M., et al. (2006) Roles of sumoylation of a reptin chromatinremodelling complex in cancer metastasis. Nat. Cell Biol. 8, 631−639 https://doi.org/10.1038/ncb1415
- Kotaja, N., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2002a) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell Biol. 22, 5222−5234 https://doi.org/10.1128/MCB.22.14.5222-5234.2002
- Kotaja, N., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2002b) The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1. J. Biol. Chem. 277, 30283−30288 https://doi.org/10.1074/jbc.M204768200
- Kwek, S. S., Derry, J., Tyner, A. L., Shen, Z., and Gudkov, A. V. (2001) Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 20, 2587−2599 https://doi.org/10.1038/sj.onc.1204362
- Lee, M. H., Lee, S. W., Lee, E. J., Choi, S. J., Chung, S. S., et al. (2006) SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination. Nat. Cell Biol. (Published online: 05 November 2006 | doi:10.1038/ncb1512)
- Li, J., Peet, G. W., Balzarano, D., Li, X., Massa, P., et al. (2001) Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276, 18579−18590 https://doi.org/10.1074/jbc.M100846200
- Mabb, A. M., Wuerzberger-Davis, S. M., and Miyamoto, S. (2006) PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat. Cell Biol. 8, 986−993 https://doi.org/10.1038/ncb1458
- Melchior, F. (2000) SUMO--nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16, 591−626 https://doi.org/10.1146/annurev.cellbio.16.1.591
- Melchior, F., Schergaut, M., and Pichler, A. (2003) SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem. Sci. 28, 612−618 https://doi.org/10.1016/j.tibs.2003.09.002
- Mo, Y. Y. and Moschos, S. J. (2005) Targeting Ubc9 for cancer therapy. Expert. Opin. Ther. Targets. 9, 1203−1216 https://doi.org/10.1517/14728222.9.6.1203
- Mo, Y. Y., Yu, Y., Theodosiou, E., Rachel Ee, P. L., and Beck, W. T. (2005) A role for Ubc9 in tumorigenesis. Oncogene 24, 2677−2683 https://doi.org/10.1038/sj.onc.1208210
- Motohashi, H., Katsuoka, F., Miyoshi, C., Uchimura, Y., Saitoh, H., et al. (2006) MafG sumoylation is required for active transcriptional repression. Mol. Cell Biol. 26, 4652−4663 https://doi.org/10.1128/MCB.02193-05
- Muller, S., Berger, M., Lehembre, F., Seeler, J. S., Haupt, Y., et al. (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275, 13321−13329 https://doi.org/10.1074/jbc.275.18.13321
- Nakayama, K. I. and Nakayama, K. (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369−381 https://doi.org/10.1038/nrc1881
- Nalepa, G., Rolfe, M., and Harper, J. W. (2006) Drug discovery in the ubiquitin-proteasome system. Nat. Rev. Drug Discov. 5, 596−613 https://doi.org/10.1038/nrd2056
- Nishida, T. and Yasuda, H. (2002) PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277, 41311−41317 https://doi.org/10.1074/jbc.M206741200
- Nishida, T., Tanaka, H., and Yasuda, H. (2000) A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267, 6423−6427 https://doi.org/10.1046/j.1432-1327.2000.01729.x
- Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N., and Yasuda, H. (1999) In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254, 693−698 https://doi.org/10.1006/bbrc.1998.9995
- Pan, Z. Q., Kentsis, A., Dias, D. C., Yamoah, K., and Wu, K. (2004) Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23, 1985−1997 https://doi.org/10.1038/sj.onc.1207414
- Pichler, A., Gast, A., Seeler, J. S., Dejean, A., and Melchior, F. (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108, 109−120
- Pickart, C. M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503−533
- Pickart, C. M. and Eddins, M. J. (2004) Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695, 55−72 https://doi.org/10.1016/j.bbamcr.2004.09.019
- Poukka, H., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl. Acad. Sci. USA 97, 14145−14150
- Rodriguez, M. S., Desterro, J. M., Lain, S., Midgley, C. A., Lane, D. P., et al. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455−6461 https://doi.org/10.1093/emboj/18.22.6455
- Rodriguez, M. S., Dargemont, C., and Hay, R. T. (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654−12659 https://doi.org/10.1074/jbc.M009476200
- Rosendorff, A., Sakakibara, S., Lu, S., Kieff, E., Xuan, Y., et al. (2006) NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. USA 103, 5308−5313
- Sachdev, S., Bruhn, L., Sieber, H., Pichler, A., Melchior, F., et al. (2001) PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15, 3088−3103 https://doi.org/10.1101/gad.944801
- Saitoh, H. and Hinchey, J. (2000) Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252−6258 https://doi.org/10.1074/jbc.275.9.6252
- Schmidt, D. and Muller, S. (2002) Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA 99, 2872−2877
- Schwarz, S. E., Matuschewski, K., Liakopoulos, D., Scheffner, M., and Jentsch, S. (1998) The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme. Proc. Natl. Acad. Sci. USA 95, 560−564
- Sentis, S., Le, R. M., Bianchin, C., Rostan, M. C., and Corbo, L. (2005) Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19, 2671−2684 https://doi.org/10.1210/me.2005-0042
- Tatham, M. H., Jaffray, E., Vaughan, O. A., Desterro, J. M., Botting, C. H., et al. (2001) Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368−35374 https://doi.org/10.1074/jbc.M104214200
- Tiefenbach, J., Novac, N., Ducasse, M., Eck, M., Melchior, F., et al. (2006) SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. Mol. Biol. Cell 17, 1643−1651 https://doi.org/10.1091/mbc.E05-07-0610
- Ulrich, H. D. (2005) Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol. 15, 525−532 https://doi.org/10.1016/j.tcb.2005.08.002
- Welchman, R. L., Gordon, C., and Mayer, R. J. (2005) Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 6, 599−609 https://doi.org/10.1038/nrm1700
- Wuerzberger-Davis, S. M., Nakamura, Y., Seufzer, B. J., and Miyamoto, S. (2006) NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage. Oncogene (online publication 24 July 2006; doi: 10.1038/sj.onc.1209815)
- Xirodimas, D. P., Chisholm, J., Desterro, J. M., Lane, D. P., and Hay, R. T. (2002) P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett. 528, 207−211 https://doi.org/10.1016/S0014-5793(02)03310-0
- Yeh, E. T., Gong, L., and Kamitani, T. (2000) Ubiquitin-like proteins: new wines in new bottles. Gene 248, 1−14 https://doi.org/10.1016/S0378-1119(00)00139-6
- Zhang, H., Saitoh, H., and Matunis, M. J. (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell Biol. 22, 6498−6508